baber/WOPTO huggingface dataset:
Patent NZ-243591-A (NZ)
Title: Digital cellular mobile radio : signal processing sequencing in half rate call mode
Inventor: DARTOIS LUC
IPC: H04W72/08
Filed: 1992-07-17
Abstract: The sequencing of signal processing applies in the reduced rate communication mode of a digital cellular radio-telephone system for conveying a digitised speech communication between a terminal and a base station by means of traffic frames (TF) each composed of time slots, the terminal having available a time slot for transmission to the base station and a time slot for reception from the base station, the communication being composed of blocks (B) corresponding to groups of speech samples, each block being formed of sub-blocks (SB) each conveyed during the slots of corresponding time of traffic frames, and is characterised in that,     - during each traffic frame (TF) there are carried out:     + a configuration processing (OP1, OP15)   + the processing of a reception time slot (OP6),   + the processing of a transmission time slot (OP13),   - during a transmission period situated outside the traffic frames, there is carried out the processing of a transmission block (OP11), - during a reception period, a particular traffic frame, there is moreover carried out the processing of a reception block (OP7).   <IMAGE>
Patent NZ-254765-A (NZ)
Title: Tablet medicament; comprises dichloromethylene diphosphonic acid (clodronic acid) or a pharmaceutically acceptable salt thereof as active ingredient and microcrystalline cellulose as auxiliary
Inventor: PREIS WALTER
IPC: A61K9/20
Filed: 1993-07-24
Abstract: The invention relates to tablets with improved bioavailability of the active ingredient dichloromethylenediphosphonic acid or a physiologically tolerated salt thereof and with a content of microcrystalline cellulose as pharmaceutical ancillary substance, to drug packs containing these tablets, to the use of the active ingredient dichloromethylenediphosphonic acid together with microcrystalline cellulose for producing a tablet with improved bioavailability, and to the process for the production of the tablet.
Patent NZ-258841-A (NZ)
Title: Dispensing closure comprising a rotatable plug mounted in a hollow closure member and a connector to rotate the plug
Inventor: CROSSDALE GARRY W
IPC: B65D83/76
Filed: 1993-12-21
Abstract: PCT No. PCT/CA93/00550 Sec. 371 Date Aug. 29, 1995 Sec. 102(e) Date Aug. 29, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14697 PCT Pub. Date Jul. 7, 1994A close for allowing the emptying of the contents of a container comprises: a hollow closure member (1) for a container, the closure member having an outlet (2) for the contents; a rotatable plug (3) mounted within the closure member, the plug having a first through-passage (4) for the contents with an inlet (32) and an outlet (34), the plug being rotatable between a first closed position in which the inlet (32) of the through-passage is out of register with the closure member outlet (2) and a second position in which the inlet is in register with the closure member outlet to permit the contents to pass into the passageway; a connector (5) for transfer of the contents out of the container, the connector having means (7) to engage the exposed portion of the plug, and the connector (5) when engaged with the plug (3) can be turned to rotate the plug to the open position, or to the closed position.
Patent NZ-264677-A (NZ)
Title: Use of substituted benzothiophenes to prepare pharmaceutical compositions for inhibiting endometriosis
Inventor: BLACK LARRY JOHN
IPC: A61K31/38
Filed: 1994-10-13
Abstract: A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula <CHEM>   Wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Patent NZ-331158-A (NZ)
Title: Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy
Inventor: KHALIL GAMAL
IPC: G01N21/35
Filed: 1997-01-31
Abstract: An apparatus is provided for determining the concentration of an analyte present in a sample using multi-spectral analysis in the near-infrared (NIR) range. Incident radiation containing a plurality of distinct, nonoverlapping spectral regions of wavelengths in the near-infrared range is used to irradiate the sample. Diffusively reflected radiation emerging from the sample is detected, and a value indicative of the concentration of the analyte is obtained therefrom, preferably using an application of chemometrics techniques. Information obtained from each of the nonoverlapping spectral regions of wavelengths can be cross-correlated to remove background interference.
Patent NZ-331629-A (NZ)
Title: Bioactivated diagnostic imaging contrast agents
Inventor: LAUFFER RANDALL B
IPC: A61K49/00
Filed: 1997-03-25
Abstract: MRI and optical imaging agents that allow for the sensitive detection of a specific bioactivity within a tissue are claimed. These agents are prodrug contrast agents that are bio-activated in vivo in the presence of the specific bioactivity. Also claimed are pharmaceutical compositions comprising these agents and methods of using the agents and compositions comprising the agents. The prodrugs have the following structure: IEM-[(PBM)m-[(MS)n-(MM)o]p]q IEM comprised of a complex between at least one physiologically compatible cyclic or acyclic organic chelating agent, and one of metal ions with atomic numbers 13, 21-34, 39-42, 44-50 or 57-83 and said IEM has one or two open coordination sites before and after bioactivation. PBM are selected from the group consisting of drugs, lipophilic and amphiphilic organic molecules, porphyrins, receptor ligands, steroids, lipids, hormones, peptides, proteins, oligonucleotides and antibodies, whereby the prodrug contrast comprises at least 2 PBMs. MS is a phosphorus-oxygen bond or a amide bond capable of being hydrolysed in vivo by a phosphatase or a serine protease enzyme respectively. MM is selected from charged groups consisting of hydroxyl, amine, ammonium, quaternary amine, amino acid, sulfoxide, phosphate, sulphate, carboxylate, carbohydrate, sugar and metal chelate. The structures of the claimed prodrugs are shown, wherein R is an aliphatic or activated ester.
Patent NZ-335202-A (NZ)
Title: Bacterial fermentation processes for 2-keto-L-gulonic acid production
Inventor: STODDARD STEVEN F
IPC: C12P7/60
Filed: 1997-10-23
Abstract: Microorganisms of strain NRRL B-21627 are cultured in a medium containing L-sorbose for a time sufficient for L-sorbose to be converted to 2-keto-L-gulonic acid. The strain is cultured at a pH of 5 to 8 and at a temp of 22 C to 35 C.  The microorganisms may be in pure culture, or mixed with an additional microorganism strain selected from the group consisting of Aureobacterium, Corynebacterium, Bacillus, Brevibacterium, Pseudomonas, Proteus, Enterobacter, Citrobacter, Erwinia, Xanthomonas and Flavobacterium.
Patent NZ-335326-A (NZ)
Title: Antiseptic soap bar comprising chlorinated methyl substituted phenol, triclosan and EDTA
Inventor: PAYNE DAVID NORMAN
IPC: A61K8/36
Filed: 1997-09-26
Abstract: An antiseptic soap bar comprising:  a)	0.35 to 0.75 % w/w of an antimicrobially active chlorinated methyl substituted phenol of formula 1, wherein R1 is chlorine or hydrogen, and R2 is methyl or hydrogen. b)	0.15 to 0.25 % w/w triclosan (or a salt thereof); and c)	less than 0.075 % w/w EDTA chelating agents.
Patent NZ-336139-A (NZ)
Title: Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
Inventor: SORENSEN ALLEN PAUL
IPC: A01N/
Filed: 1999-06-04
Abstract: A storage stable veterinary composition comprises: (i) at least one active ingredient that is lipophilic in character and (ii) at least one organic liquid carrier which carries at least most of the lipophilic active ingredients, thereby defining an organic liquid phase, (iii) levamisole, and (iv) at least water which carries at least most of the levamisole thereby defining an aqueous phase, wherein the aqueous phase has a pH of less than 7, there is present in the aqueous phase an emulsifying agent or agents, and the phases exist in, or can be shaken or agitated into, the form of an emulsion with the particulate content, if any, at least substantially present in the aqueous phase. An anthelmintic composition comprising 0.08% by weight of ivermectin; 3% by weight of levamisole, and 2% by weight of albendazole wherein the albendazole is particulate and is at least in part in an aqueous phase with the levamisole, such aqueous phase being buffered to a pH appropriate for the levamisole and its stability and the ivermectin is substantially in the organic phase from the levamisole. A storage stable pourable veterinary composition comprises:  up to 25% w/v of at least one first active pesticide soluble in an organic phase and 1 to 60% w/v of an first liquid organic phase in which the first active is at least substantially soluble, 0-5% w/v of a co-solvent for the first active and 1 to 15% w/v of an emulsifying agent, 0 to 20% w/v of at least one further second pesticidal active not substantially soluble in the first phase and a second liquid phase, wherein the composition having at least most of the first active in the organic phase and the organic phase being emulsified in the second liquid phase which includes the second active when present.
Patent NZ-336927-A (NZ)
Title: Video camera activated by magnetic stripe card, smart card, key that stores visual data in a database, then transmits the data to a server and eventually a website
Inventor: AVISON PETER
IPC: H04B1/00
Filed: 1999-07-28
Abstract: A video camera is activated by a magnetic stripe card, smart card, barcode or similar "key", to store recorded images in a database.  The recorded images and associated audio record is transmitted to a server from which the images may be presented on a website.
Patent NZ-338008-A (NZ)
Title: Pyrazolo[3,4-d]pyrimidinedione compounds
Inventor: CHESHIRE DAVID
IPC: A61K31/415
Filed: 1998-04-07
Abstract: A compound of formula (I) wherein: R1 is alkyl, alkenyl or cycloalkyl; R2 is alkyl or alkenyl; R3 is 1- or 2-indanyl, 1- or 2-(1,2,3,4-tetrahydronaphthalenyl), 9-fluorenyl, acenaphthyl or CHR4(CH2)nAr wherein n is 0 or 1, R4 is hydrogen or alkyl and Ar is quinolinyl, naphthalenyl, benzodioxolinyl optionally substituted by one or more halogen atoms, or phenyl optionally substituted by one or more substituent groups selected from halogen, alkyl, alkoxy and phenylsulfonylmethyl; W is H, CH2 OH, CO2 H, CO2alkyl, CH2NR5R6, CONR5R6, wherein R5 and R6 are independently hydrogen or alkyl, or W is pyridyl or phenyl, each of which may be optionally substituted by one or more substituent groups selected from halogen, hydroxyl, alkyl and alkoxy; X is a bond or alkylene; Y is S(O)p, C=C, CH=CH, CH2CH2 or CH2CH=CH; and p is 0, 1 or 2; or a pharmaceutically acceptable salt thereof, provided that X is not a bond when W is H, CH2 OH, CO2 H, CO2 C1-6 alkyl, CH2 NR5 R6 or CONR5 R6 and Y is sulfur.
Patent NZ-503757-A (NZ)
Title: Substituted oximes as antagonists of tachykinin receptors
Inventor: REICHARD GREGORY A
IPC: C07D211/52
Filed: 1998-11-18
Abstract: Compounds within the genus represented by structural formula (I) or a pharmaceutically acceptable salt thereof, wherein: T is substituted phenyl or substituted pyridyl; R1 is H, methyl, ethyl, -CH2CN, -CH2C(O)NH2, -(CH2)3SO3H, -CH2C(O)NHCH3, -CH2C(O)NHOH, -CH2C(O)NHOCH3, -CH2C(O)NHCH2CN, -CH2F, -CH2C(O)NHCH2SO3H, (a), (b), (c), (d) or (e); R4 is methyl or ethyl; and Z is substituted piperidinyl are useful in the treatment of conditions such as asthma, cough, chronic obstructive pulmonary disease (COPD), bronchospasm, emesis, neurodegenerative disease, ocular disease, inflammatory diseases such as arthritis, central nervous system conditions such as migraine and epilepsy, nociception, psychosis, and various gastrointestinal disorders such as Crohn's disease.
Patent NZ-506574-A (NZ)
Title: Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
Inventor: ASAI FUMITOSHI
IPC: C07D207/04
Filed: 1999-02-26
Abstract: A cyclic amino derivative or a pharmacologically acceptable salt thereof has the formula (I) R3-C(R1)(R2)H wherein R1 is optionally substituted phenyl group; R2 is an alkoxycarbonyl group or an optionally substituted aliphatic acyl group or benzoyl group; R3 is a saturated 2 to 8-membered cyclic amino group in one or more rings with the largest nitrogen containing ring having from 3-7 ring atoms; the saturated cyclic amino group is substituted by -S-X-R4 and is attached via a ring nitrogen atom thereof to the adjacent carbon atom to which the substituents R1 and R2 are attached; the saturated cyclic amino group optionally contains a further ring heteroatom of O or S and may optionally be further substituted with a group having the formula =CR5R6; R4 is a cycloalkyl group or optionally substituted phenyl group or alkyl group; X is sulphur, sulphinyl or sulphonyl and R5 and R6 are independently hydrogen, alkyl, carboxyl, alkoxycarbonyl, carbamoyl, alkylcarbamoyl or dialkylcarbamoyl. The compounds are useful for treating embolism, thrombosis or arteriosclerosis.
Patent NZ-506734-A (NZ)
Title: Method of manufacturing novelty shaped food products using an elastomeric mould, the mould, and the novelty shaped paste coated food product formed by this method
Inventor: HAASE MARK
IPC: A23P1/10
Filed: 2000-09-05
Abstract: A method of producing novelty-shaped pasta pieces using a flexible elastomeric mould to mould unshaped pasta pieces.
Patent NZ-510167-A (NZ)
Title: Alginate capsules for use in the treatment of brain tumour
Inventor: BJERKVIG ROLF
IPC: A61K35/54
Filed: 1999-08-25
Abstract: An encapsulated producer cell capable of expressing  a molecule  which is an inhibitor of CNS tumour  growth.   The encapsulation matrix is an immunoisolating alginate  with  a G  content  of  above  15% and the  molecule  is  either  a) capable   of   interacting  with  tumour/host  communication pathways;   or   b)   is   capable   if   affecting   tumour neovascularisation;  or c) is capable  of  interfering  with the  relationship of the tumour cell with the  extracellular matrix;   or   d)  is  a  monoclonal  antibody  capable   of interacting directly with a receptor of the tumour.
Patent NZ-510325-A (NZ)
Title: Sheet feeder with sheet taken in one direction and fed out in a different direction with alignment during feed out
Inventor: BARRAND PHILLIP NEIL
IPC: B65H29/16
Filed: 2001-03-06
Abstract: A sheet feeder (10) for feeding sheets (14) of paper from a printer to a downstream processor, said feeder serving to receive the sheet from the printer in a first direction (24) and comprising first feed means for feeding the sheet to the downstream processor in a second direction whereby to change the orientation of the sheet, and alignment means for aligning the sheet in the second direction.
Patent NZ-513778-A (NZ)
Title: A multilayered packaging film having at least three layers with the first layer comprising a copolymer of propene and at least one alpha olefin
Inventor: IDLAS SCOTT A
IPC: B32B7/12
Filed: 2001-08-24
Abstract: A multilayer packaging film having at least four layers arranged in sequence comprises: (1) a first layer comprising at least 50% by weight of a metallocene catalyzed copolymer of propene and at least one a -olefin of ethylene, 1-butene, 1-methylpentene, 1-hexene, 1-octene, 1-decene or mixtures thereof with the copolymer has a propene content of at least 60 wt.%, a Tm between 100 and 145oC, a Mw/Mn between 1 and 5, and n-hexane extractables of less than 5 wt.%; (2) second and fourth layers each comprising: (a) at least 10 wt.% of a first copolymer of ethylene and at least one a -olefin with the copolymer having a density of 0.900 to 0.915 g/cm and a melt index of less than 2 dg/min., (b) at least 10 wt.% of a second copolymer of ethylene with 4 to 18 wt.% of a vinyl ester, alkyl acrylate, acrylic or methacrylic acid, and (c) 0 to 60 wt.% of a third copolymer of ethylene and at least one a-olefin having a density less than 0.900 g/cm and a melting point between 65-98oC and (3) a third layer comprising at least 80% by weight of at least one copolymer of vinylidene chloride with from 2-20 wt.% (based on the copolymer) of vinyl chloride or methyl acrylate. A multi-layer biaxially oriented heat-shrinkable packaging film comprises: (4) a heat-sealing first layer as defined above in part 1); (5) a second layer as defined above in part 2) and (6) a transition layer between and in contact with the first layer and the second layer comprising: (a) at least 20% by weight of a fourth copolymer of propene, and at least one a-olefin of ethylene, 1-butene, 1-methylpentene, 1-hexene, 1-octene, 1-decene or mixtures thereof with the copolymer having a propene content of at least 60 wt. %, a Tm between 100 and 145OC, a Mw/Mn between 1 and 5, and n-hexane extractables of less than 5 wt. %, (b) at least 20% by weight of a fifth copolymer of ethylene and at least one a -olefin with the copolymer having a density of 0.900 to 0.915 g/cm and a melt index of less than 2 dg/min., and (c) 0 to 60 wt. % of a sixth copolymer of ethylene and at least one a -olefin having a density less than 0.900 g/cm and a melting point between 65-98oC. A multi-layer packaging film formable into a pouch by heat-sealing for use in food preparation comprises: (7) a heat-sealing first layer as defined above in part 1); (8) a second layer as defined above in part 2)  and (9) an optional third layer comprising a protective outer layer.
Patent NZ-514064-A (NZ)
Title: Pesticidal enantiomer-pure 2,4-disubstituted oxazolines
Inventor: FROELICH OLIVIER
IPC: A61P33/14
Filed: 2000-03-24
Abstract: An enantiomer of 2-(2,6-difluorophenyl)-4-(4'-trifluoromethylbiphenyl-4-yl)-4,5-dihydro-oxazole (formula I) has a negative option rotation of aD (589nm NaD) in methanol. The compound is useful for treating ectoparasites and endoparasites.
Patent NZ-518692-A (NZ)
Title: Purified fibrinogen free of destabilising levels of plasminogen and other proteases obtained from a Fraction I paste
Inventor: KANELLOS JERRY
IPC: C07K1/18
Filed: 2000-12-21
Abstract: Methods for purifying fibrinogen are described, in particular a method of separating fibrinogen from plasma fraction I precipitate. Also described is the purification of fibrinogen using ion-exchange chromatography wherein the addition of at least one ù-amino acid, such as å-amino caproic acid (EACA), to the wash buffer of the ion-exchange step results in an enhanced yield and greater stability of fibrinogen concentrate relative to the absence of the ù-amino acid in the wash buffer.
Patent NZ-519558-A (NZ)
Title: Process for the production of flexible to semi-rigid polyurethane integral foams
Inventor: EISEN NORBERT
IPC: C08J9/34
Filed: 2000-12-04
Abstract: A process for the production of flexible to semi-rigid polyurethane shaped articles with a compacted edge zone of given hardness and a significantly more flexible cell core, so-called integral foams, in which non-combustible mixtures of fluoroalkanes which comprise 1,1,1,3,3-pentafluorobutane (R 365mfc) are employed as physical blowing agents is disclosed, wherein the process for the production of flexible to semi-rigid polyurethane shaped articles with a compacted edge zone and a flexible, cellular core, comprises: a) organic and/or modified organic polyisocyanates and/or polyisocyanate prepolymers are reacted with b) at least one polyol component with an OH number of 20 to 200 and a functionality of 2 to 6, c) optionally in combination with a polyol component with an OH number of 201 to 899 and a functionality of 2 to 3, and d) at least one chain lengthening component with an OH or amine number of 600 to 1,850 and a functionality of 2 to 4 and e) optionally additives, activators and/or stabilizers which are known per se in the presence of water and in the presence of 1,1,1,3,3- pentafluorobutane and blowing agent mixtures comprising at least one further fluoroalkane.
Patent NZ-520181-A (NZ)
Title: Golf game using radio frequency identifiable golf balls and antennas and computer to track balls
Inventor: JOLLIFFE STEVEN PAUL
IPC: A63B57/00
Filed: 2001-01-04
Abstract: A golf game employing r.f.-tag coded golf balls has a playing area (14) with r.f. antennae (20) located underneath to enable the number of strokes taken by a player to be counted. Separate antennae (22 and 26) are provided for the tee area (12) and hole (16), respectively, and the antennae (21) around the hole are smaller to improve resolution. The antennae (20, 21, 22, 26) are connected to a computer (30) which monitors successive moving and stationary phases of a golf ball to count the number of strokes taken by a player.
Patent NZ-527646-A (NZ)
Title: A dual-walled rubbish bin with cooling fins on the inner wall to dissipate heat in case of fire.
Inventor: BODEN DEREK WILLIAM
IPC: B65F1/14
Filed: 2003-08-18
Abstract: An enclosure having at least one peripheral wall having an inner wall and an outer wall spaced there from to provide a passage between the inner wall and the outer wall through which air may flow, a plurality of cooling fins projecting from the inner wall and towards the outer wall whereby air may flow between the inner and outer walls and over the fins.
Patent NZ-535750-A (NZ)
Title: Film coating for controlled release of pharmaceutical drugs
Inventor: KARLSSON OLA J
IPC: C08F220/00
Filed: 2003-04-09
Abstract: Disclosed herein is a film coating dispersion obtained by the polymerization of the following monomers in water: acrylic acid or an ester thereof in the range 40 to 80 % by weight; methacrylic acid or an ester thereof in the range 20 to 60 % by weight; and a polymerizable surfactant in the range 0.01 to 9 % by weight. The dispersion is suitable for coating pharmaceutical formulations to provide controlled release of the active ingredient.
Patent NZ-535805-A (NZ)
Title: Starch sub-types and lipid metabolism
Inventor: BROWN IAN LEWIS
Filed: 2001-04-06
Abstract: Disclosed is a method for modifying an individual's diet, comprising preparing a pre-packaged diet in which the diet comprises replacing a least 5% of the individual's daily carbohydrate intake with amylase starch and at least 10% of the individual's saturated fat intake with unsaturated fat. The pre-packaged diet may also be used for improving energy utilisation in an individual during exercise.
Patent NZ-539403-A (NZ)
Title: Modular drawer appliance for heating or cooling products with insulation in drawer space
Inventor: LECLEAR DOUGLAS D
IPC: A47B88/00
Filed: 2005-04-12
Abstract: A modular cabinet is disclosed for a family of drawer appliances including an insulated liner defining a drawer space, a machine compartment, a wiring harness leading from the machine compartment to the drawer space, a passage leading from the machine compartment to the drawer space and an air passage leading from the machine compartment to the front of the cabinet and a drain leading from the liner space to the machine compartment. The family of drawer appliances can include refrigerator, freezer, ice maker, wine and warming drawers. A drawer can have two compartments and can be maintained at two temperatures. The drawers include an insulated front and a bin and can be slidably carried in the drawer space. The modular cabinet and control can be used for each member of the family of drawer appliances.